Copelink Blog

CancerCare, in partnership with LUNGevity Foundation, is interested in understanding the burden of financial toxicity associated with lung cancer diagnosis and treatment. Through a semi-structured survey, LUNGevity and CancerCare wish to understand:

1. What are the major financial concerns of a lung cancer patient or a caregiver?


2. How do underlying factors intersect to influence financial toxicity associated with lung cancer treatment?
• Type of lung cancer (stage and histology)
• Time of diagnosis
• Age
3. How do outward factors intersect to influence financial toxicity associated with lung cancer treatment?
• Income
• Geographical location
• Ethnicity
• Education level
• Insurance
• Total OOP expenditure in the past 6 months
• Number of treatments received
• Number of treatment options available

For a patient (or a caregiver to be eligible), the patient has to be in active treatment or have undergone lung cancer treatment in the past one year.

Click here to complete the survey.